EXC vs ORMP
Exelon Corporation (EXC) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.
Exelon Corporation (EXC) is a utilities - regulated electric company listed on NASDAQ.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
Latest reported EXC revenue for 2024-12-31 was $23.03B. Net income was $2.46B. Revenue was up 6.0% from 2023-12-31 to 2024-12-31. EXC currently screens at market cap $47.33B and trailing P/E 16.8.
Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.
EXC currently screens at market cap $47.33B and trailing P/E 16.8. ORMP currently screens at market cap $87.2M.
Not investment advice. Open the EXC and ORMP stock pages for the full models.
Not investment advice.